Here are five key notes:
1. The new patent is titled “Systems and Methods for the Fusion of the Sacral-Illiac Joint” and describes placing an “elongated implant structure having a longitudinal axis and a rectilinear cross section transverse to the longitudinal axis and including an exterior surface region treated to provide bony in-growth or through-growth along the implant structure…with an axially applied, non-rotational force.”
2. The patent covers a fusion cage structure and insertion path “created in a non-invasive manner without prior removal of cartilage.” The patent also describes “inserting the bone fixation implant through a posterolateral insertion path.”
3. SI-BONE now has 16 United States patents and another 26 patents pending. Outside of the United States, the company has one patent and four patents pending.
4. There are publications showing the SI joint is the pain generator for 15 percent to 30 percent of low back pain patients and SI joint pain occurs in 43 percent of failed back surgery patients.
5. SI-BONE developed the iFuse Implant System, which has FDA clearance and the CE mark.
“This broad patent adds to SI-BONE’s extensive patent portfolio describing fusion methods that can be used to develop products for the SI joint and other areas of the body,” said SI-BONE Vice President and Chief Technology Officer Scott Yerby, PhD. “This patent also describes an SI joint insertion path that is somewhat different than SI-BONE’s current technique.”
More articles on orthopedic devices:
DJO Global to launch Exprt Precision System for knee revisions
Intellijoint Surgical to introduce hip surgery tool in the U.S.
10 things to know about the PRP market through 2020
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.